세계의 생물학적 피부 대체물 시장 규모 조사 : 유형별, 용도별, 최종 용도별, 지역별 예측(2022-2032년)

Global Biological Skin Substitutes Market is valued at approximately USD 323.31 million in 2023 and is anticipated to grow with a healthy growth rate of more than 8.86% over the forecast period 2024-2032. Biological skin substitutes are engineered tissue products designed to provide temporary or permanent coverage for exposed skin wounds, restoring skin function. These products are widely used in treating chronic, non-healing ulcers and for wound coverage in burn and trauma cases. The increasing prevalence of chronic wounds and a rising number of burn and trauma incidents are expected to drive market growth. Moreover, the growing demand for affordable skin replacement solutions and the adoption of advanced wound care facilities globally are further expected to propel market expansion.

The Global Biological Skin Substitutes Market is driven by rising incidence of chronic wounds and trauma cases necessitates effective treatment options, which has led to a heightened demand for biological skin substitutes. Chronic wounds, such as diabetic neuropathic ulcers, pressure ulcers, and vascular insufficiency ulcers, pose significant challenges to healthcare providers, emphasizing the need for advanced wound care solutions. Biological skin substitutes are increasingly been utilized to manage these conditions, offering both temporary and permanent solutions that aid in restoring skin functionality and promoting healing. Moreover, rising adoption of advanced wound care facilities is anticipated to create lucrative opportunities for the market. However, lack of skilled professionals is going to impede the overall demand for the market during the forecast period 2024-2032.

The key regions considered for the Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North America held the largest market share driven by a well-developed healthcare infrastructure, increased awareness about wound management, and substantial healthcare expenditure in the U.S. and Canada. The region's advanced healthcare facilities and supportive reimbursement policies further contribute to its market dominance. Furthermore, the Asia Pacific region is projected to grow at the fastest CAGR during the forecast period. Rapid economic growth, coupled with a rising demand for innovative wound management technologies, is anticipated to drive market growth in this region. Efforts to develop tailored solutions for effective wound care are expected to boost the adoption of biological skin substitutes.

The major market players included in this report are:

• Organogenesis, Inc.
• 3M
• Integra LifeSciences
• Smith and Nephew
• Tissue Regenix
• Mimedx
• BSN medical
• Stryker
• Vericel Corporation
• Mallinckrodt

The detailed segments and sub-segment of the market are explained below:

By Type:

• Human Donor Tissue-Derived Products
• Acellular Animal-derived Products

By Application:

• Acute Wounds
• Chronic Wounds

By End-use:

• Hospitals
• Outpatient Facilities
• Research and Manufacturing

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• RoLA
• Middle East & Africa
• Saudi Arabia
• South Africa
• RoMEA

Years considered for the study are as follows:

• Historical year - 2022
• Base year - 2023
• Forecast period - 2024 to 2032

Key Takeaways:

• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market

Table of Contents

Chapter 1. Global Biological Skin Substitutes Market Executive Summary

• 1.1. Global Biological Skin Substitutes Market Size & Forecast (2022-2032)
• 1.2. Regional Summary
• 1.3. Segmental Summary
  • 1.3.1. By Type
  • 1.3.2. By Application
  • 1.3.3. By End-use
• 1.4. Key Trends
• 1.5. Recession Impact
• 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Biological Skin Substitutes Market Definition and Research Assumptions

• 2.1. Research Objective
• 2.2. Market Definition
• 2.3. Research Assumptions
  • 2.3.1. Inclusion & Exclusion
  • 2.3.2. Limitations
  • 2.3.3. Supply Side Analysis
    • 2.3.3.1. Availability
    • 2.3.3.2. Infrastructure
    • 2.3.3.3. Regulatory Environment
    • 2.3.3.4. Market Competition
    • 2.3.3.5. Economic Viability (Consumer's Perspective)
  • 2.3.4. Demand Side Analysis
    • 2.3.4.1. Regulatory frameworks
    • 2.3.4.2. Technological Advancements
    • 2.3.4.3. Environmental Considerations
    • 2.3.4.4. Consumer Awareness & Acceptance
• 2.4. Estimation Methodology
• 2.5. Years Considered for the Study
• 2.6. Currency Conversion Rates

Chapter 3. Global Biological Skin Substitutes Market Dynamics

• 3.1. Market Drivers
  • 3.1.1. Rise in Incidence of Chronic Wounds and Trauma Cases
  • 3.1.2. Increasing Demand for Affordable Skin-Replacement Solutions
• 3.2. Market Challenges
  • 3.2.1. Lack of Skilled Professionals
• 3.3. Market Opportunities
  • 3.3.1. Growing Adoption of Advanced Wound Care Facilities
  • 3.3.2. Expansion in Emerging Markets

Chapter 4. Global Biological Skin Substitutes Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
  • 4.1.6. Futuristic Approach to Porter's 5 Force Model
  • 4.1.7. Porter's 5 Force Impact Analysis
• 4.2. PESTEL Analysis
  • 4.2.1. Political
  • 4.2.2. Economical
  • 4.2.3. Social
  • 4.2.4. Technological
  • 4.2.5. Environmental
  • 4.2.6. Legal
• 4.3. Top investment opportunity
• 4.4. Top winning strategies
• 4.5. Disruptive Trends
• 4.6. Industry Expert Perspective
• 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Biological Skin Substitutes Market Size & Forecasts by Type 2022-2032

• 5.1. Segment Dashboard
• 5.2. Global Biological Skin Substitutes Market: Type Revenue Trend Analysis, 2022 & 2032 (USD Million)
  • 5.2.1. Human Donor Tissue-Derived Products
  • 5.2.2. Acellular Animal-derived Products

Chapter 6. Global Biological Skin Substitutes Market Size & Forecasts by Application 2022-2032

• 6.1. Segment Dashboard
• 6.2. Global Biological Skin Substitutes Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Million)
  • 6.2.1. Acute Wounds
  • 6.2.2. Chronic Wounds

Chapter 7. Global Biological Skin Substitutes Market Size & Forecasts by End-use 2022-2032

• 7.1. Segment Dashboard
• 7.2. Global Biological Skin Substitutes Market: End-use Revenue Trend Analysis, 2022 & 2032 (USD Million)
  • 7.2.1. Hospitals
  • 7.2.2. Outpatient Facilities
  • 7.2.3. Research and Manufacturing

Chapter 8. Global Biological Skin Substitutes Market Size & Forecasts by Region 2022-2032

• 8.1. North America Biological Skin Substitutes Market
  • 8.1.1. U.S. Biological Skin Substitutes Market
    • 8.1.1.1. Type breakdown size & forecasts, 2022-2032
    • 8.1.1.2. Application breakdown size & forecasts, 2022-2032
    • 8.1.1.3. End-use breakdown size & forecasts, 2022-2032
  • 8.1.2. Canada Biological Skin Substitutes Market
• 8.2. Europe Biological Skin Substitutes Market
  • 8.2.1. UK Biological Skin Substitutes Market
  • 8.2.2. Germany Biological Skin Substitutes Market
  • 8.2.3. France Biological Skin Substitutes Market
  • 8.2.4. Spain Biological Skin Substitutes Market
  • 8.2.5. Italy Biological Skin Substitutes Market
  • 8.2.6. Rest of Europe Biological Skin Substitutes Market
• 8.3. Asia-Pacific Biological Skin Substitutes Market
  • 8.3.1. China Biological Skin Substitutes Market
  • 8.3.2. India Biological Skin Substitutes Market
  • 8.3.3. Japan Biological Skin Substitutes Market
  • 8.3.4. Australia Biological Skin Substitutes Market
  • 8.3.5. South Korea Biological Skin Substitutes Market
  • 8.3.6. Rest of Asia Pacific Biological Skin Substitutes Market
• 8.4. Latin America Biological Skin Substitutes Market
  • 8.4.1. Brazil Biological Skin Substitutes Market
  • 8.4.2. Mexico Biological Skin Substitutes Market
  • 8.4.3. Rest of Latin America Biological Skin Substitutes Market
• 8.5. Middle East & Africa Biological Skin Substitutes Market
  • 8.5.1. Saudi Arabia Biological Skin Substitutes Market
  • 8.5.2. South Africa Biological Skin Substitutes Market
  • 8.5.3. Rest of Middle East & Africa Biological Skin Substitutes Market

Chapter 9. Competitive Intelligence

• 9.1. Key Company SWOT Analysis
• 9.2. Top Market Strategies
• 9.3. Company Profiles
  • 9.3.1. Organogenesis, Inc.
    • 9.3.1.1. Key Information
    • 9.3.1.2. Overview
    • 9.3.1.3. Financial (Subject to Data Availability)
    • 9.3.1.4. Product Summary
    • 9.3.1.5. Market Strategies
  • 9.3.2. 3M
  • 9.3.3. Integra LifeSciences
  • 9.3.4. Smith and Nephew
  • 9.3.5. Tissue Regenix
  • 9.3.6. Mimedx
  • 9.3.7. BSN medical
  • 9.3.8. Stryker
  • 9.3.9. Vericel Corporation
  • 9.3.10. Mallinckrodt

Chapter 10. Research Process

• 10.1. Research Process
  • 10.1.1. Data Mining
  • 10.1.2. Analysis
  • 10.1.3. Market Estimation
  • 10.1.4. Validation
  • 10.1.5. Publishing
• 10.2. Research Attributes